Clinical Trial Update: Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial comparing PRO-174 to Sophixín Ofteno® for safety and tolerability on the ocular surface in healthy subjects; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis
• Conjunctivitis Bacterial

Drugs mentioned

• PRO-174
• Sophixín Ofteno®

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Conjunctivitis, Conjunctivitis, Bacterial | Phase 1 | Status: COMPLETED | Results posted: 2019-10-25